Applications of Physiologically Based Pharmacokinetic Modeling of Rivaroxaban—Renal and Hepatic Impairment and Drug‐Drug Interaction Potential-Reference-Cited by-同舟云学术

Applications of Physiologically Based Pharmacokinetic Modeling of Rivaroxaban—Renal and Hepatic Impairment and Drug‐Drug Interaction Potential

Published:2021-01-06 Issue:5 Volume:61 Page:656-665
ISSN:0091-2700
Container-title:The Journal of Clinical Pharmacology
language:en
Short-container-title:The Journal of Clinical Pharmacology

Author:

Willmann Stefan¹,Coboeken Katrin¹,Kapsa Stefanie²,Thelen Kirstin²,Mundhenke Markus³,Fischer Kerstin⁴,Hügl Burkhard⁵,Mück Wolfgang²

Affiliation:

1. Clinical Pharmacometrics Bayer AG Wuppertal Germany

2. Clinical Pharmacokinetics Cardiovascular Bayer AG Wuppertal Germany

3. Medical Affairs Cardiovascular Bayer Vital GmbH Leverkusen Germany

4. Bayer Healthcare Köln Germany

5. Clinic for Cardiology and Rhythmology Marienhaus Klinikum St Elisabeth Neuwied Neuwied Germany

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcph.1784

Reference68 articles.

1. Janssen Pharmaceuticals Inc. Xarelto (rivaroxaban) prescribing information.2020.http://www.janssenlabels.com/package-insert/product-monograph/prescribing-information/XARELTO-pi.pdf. Accessed October 5 2020.

2. BayerAG.Xarelto®(rivaroxaban) summary of product characteristics.https://www.ema.europa.eu/documents/product-information/xarelto-epar-product-information_en.pdf. Published 2020. Accessed July 30 2020.

3. Bayer Inc. Xarelto® (rivaroxaban tablets) product monograph.http://omr.bayer.ca/omr/online/xarelto-pm-en.pdf. Published 2019. Accessed February 10 2020.

4. Bodyweight-adjusted rivaroxaban for children with venous thromboembolism (EINSTEIN-Jr): results from three multicentre, single-arm, phase 2 studies

5. Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trial

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In Silico and In Vivo Pharmacokinetic Evaluation of 84-B10, a Novel Drug Candidate against Acute Kidney Injury and Chronic Kidney Disease;Molecules;2023-12-27

2. Application of validated UV spectrophotometric and colorimetric method to quantify minoxidil in the development of trilayer dissolving microneedle: Proof of concept in ex vivo and in vivo studies in rats;Annales Pharmaceutiques Françaises;2023-12

3. Physiologically-based pharmacokinetic modeling for optimal dosage prediction of olaparib when co-administered with CYP3A4 modulators and in patients with hepatic/renal impairment;Scientific Reports;2023-09-25

4. Physiologically based pharmacokinetic (PBPK) modelling of oral drug absorption in older adults – an AGePOP review;European Journal of Pharmaceutical Sciences;2023-09

5. A physiologically based pharmacokinetic model of cefepime to predict its pharmacokinetics in healthy, pediatric and disease populations;Saudi Pharmaceutical Journal;2023-08